Evidence map›Paper›PMID 30478052›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Citrate-based materials fuel human stem cells by metabonegenic regulation.

Chuying Ma, Xinggui Tian, Jimin P Kim, Denghui Xie, Xiang Ao, Dingying Shan, Qiaoling Lin, Maria R Hudock, Xiaochun Bai, Jian Yang

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 122 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. BiomimeticInternational journal of molecular sciences · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Chuying MaDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16801.
Xinggui TianAcademy of Orthopedics, Guangdong Province, Guangdong Provincial Key Laboratory of Bone and Joint Degenerative Diseases, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510280, China.
Jimin P KimDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16801.
Denghui XieDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16801.
Xiang AoAcademy of Orthopedics, Guangdong Province, Guangdong Provincial Key Laboratory of Bone and Joint Degenerative Diseases, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510280, China.
Dingying ShanDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16801.
Qiaoling LinDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16801.
Maria R HudockDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16801.
Xiaochun BaiAcademy of Orthopedics, Guangdong Province, Guangdong Provincial Key Laboratory of Bone and Joint Degenerative Diseases, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510280, China; jxy30@psu.edu baixc15@smu.edu.cn.
Jian YangDepartment of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16801; jxy30@psu.edu baixc15@smu.edu.cn.
Pennsylvania State University · USThird Affiliated Hospital of Southern Medical University · CNSouthern Medical University · CN

Funding

Citrate Metabonegenic Regulation for the next Generation of Orthopedic Biomaterial DesignR01AR072731 · NIAMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI YANG, JIAN · 2018 to 2022
$1.7M
Developing targeted therapy with prostate cancer specific nanomedicineR01CA182670 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HSIEH, JER-TSONG, YANG, JIAN · 2013 to 2017
$1.6M
Chromatic two-photon fluorescence microsopy using band-shifting imaging probesR21EB024829 · NIBIB · PENNSYLVANIA STATE UNIVERSITY, THE · PI LIU, ZHIWEN, YANG, JIAN · 2017 to 2018
$410k
NCI NIH HHS R01 CA182670NIAMS NIH HHS R01 AR072731NIBIB NIH HHS R21 EB024829
6 · The paper itself

Abstract

A comprehensive understanding of the key microenvironmental signals regulating bone regeneration is pivotal for the effective design of bioinspired orthopedic materials. Here, we identified citrate as an osteopromotive factor and revealed its metabonegenic role in mediating citrate metabolism and its downstream effects on the osteogenic differentiation of human mesenchymal stem cells (hMSCs). Our studies show that extracellular citrate uptake through solute carrier family 13, member 5 (SLC13a5) supports osteogenic differentiation via regulation of energy-producing metabolic pathways, leading to elevated cell energy status that fuels the high metabolic demands of hMSC osteodifferentiation. We next identified citrate and phosphoserine (PSer) as a synergistic pair in polymeric design, exhibiting concerted action not only in metabonegenic potential for orthopedic regeneration but also in facile reactivity in a fluorescent system for materials tracking and imaging. We designed a citrate/phosphoserine-based photoluminescent biodegradable polymer (BPLP-PSer), which was fabricated into BPLP-PSer/hydroxyapatite composite microparticulate scaffolds that demonstrated significant improvements in bone regeneration and tissue response in rat femoral-condyle and cranial-defect models. We believe that the present study may inspire the development of new generations of biomimetic biomaterials that better recapitulate the metabolic microenvironments of stem cells to meet the dynamic needs of cellular growth, differentiation, and maturation for use in tissue engineering.

Indexed as

Adenosine TriphosphateAnimalsBiocompatible MaterialsBiopolymersBone RegenerationCell AdhesionCell DifferentiationCell ProliferationCitric AcidDisease Models, AnimalFemoral FracturesHumansMaleMesenchymal Stem CellsMetabolic Networks and PathwaysModels, BiologicalAdenosine TriphosphateBiocompatible MaterialsBiopolymersCitric AcidPhosphoserineSLC13A5 protein, humanSymporterscitrate-based materialsenergy metabolismmetabonegenic regulationphosphoserinestem cells

Identifiers

PMID30478052
PMCPMC6294936
OpenAlexW2903369963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.